SIKA Stock Analysis: Sika | SW
Specialty Chemicals | SW, Switzerland | Market Cap: 29.489m CHF | 12M Return: -0.9% | CH0418792922 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 67.6M
Qual. Beats: 0
Rev. Trend: 79.4%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sika AG is a Swiss specialty chemicals company that develops and sells chemical systems for bonding, sealing, damping, reinforcing, and protecting applications. Its business is split between two principal end markets: the building sector and the motor vehicle industry, with operations spanning multiple regions worldwide.
The product portfolio covers concrete admixtures and additives, waterproofing systems (SikaProof), flat roofing membranes (Sika Sarnafil), tile adhesives and grouts, resin and cementitious flooring, and sealants. Beyond core construction, the company supplies automotive and commercial vehicle assembly, industrial lamination, renewable energy, home appliances, and advanced resins.
Sika operates a B2B model, selling through direct relationships and distribution to construction contractors, industrial OEMs, and project specifiers. Founded in 1910 and headquartered in Baar, Switzerland, the company sits within the GICS Specialty Chemicals sub-industry, where competitors typically include other diversified construction-chemicals and adhesives manufacturers.
- Infrastructure and non-residential construction demand boosts admixture sales
- Automotive segment exposed to EV transition and OEM production cuts
- Raw material cost inflation pressures specialty chemicals margins
| Net Income: 1.91b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.22 > 1.0 |
| NWC/Revenue: 5.79% < 20% (prev 8.95%; Δ -3.16% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.59b > Net Income 1.91b |
| Net Debt (5.88b) to EBITDA (3.30b): 1.78 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (160.7m) vs 12m ago 0.19% < -2% |
| Gross Margin: 48.35% > 18% (prev 35.02%; Δ 13.33% > 0.5%) |
| Asset Turnover: 125.4% > 50% (prev 134.7%; Δ -9.32% > 0%) |
| Interest Coverage Ratio: 17.49 > 6 (EBIT TTM 2.76b / Interest Expense TTM 157.9m) |
| A: 0.07 (Total Current Assets 4.95b - Total Current Liabilities 3.81b) / Total Assets 16.0b |
| B: 0.44 (Retained Earnings 7.04b / Total Assets 16.0b) |
| C: 0.18 (EBIT TTM 2.76b / Avg Total Assets 15.7b) |
| D: 0.74 (Book Value of Equity 6.81b / Total Liabilities 9.20b) |
| Altman-Z'' = 3.86 = AA |
| DSRI: 1.19 (Receivables 2.68b/2.37b, Revenue 19.7b/20.7b) |
| GMI: 0.72 (GM 35.02% / 48.35%) |
| AQI: 0.97 (AQ_t 0.53 / AQ_t-1 0.54) |
| SGI: 0.95 (Revenue 19.7b / 20.7b) |
| TATA: 0.02 (NI 1.91b - CFO 1.59b) / TA 16.0b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of October 07, 2026, the stock is trading at CHF 175.50 with a total of 441,649 shares traded. Over the past week, the price has changed by -5.31%, over one month by -9.23%, over three months by +1.89% and over the past year by -0.91%.
Current recommended Stop Loss: 169.50 (which is 3.4% or 1.2 ATR below the current price).
Sika has no consensus analysts rating.
P/E Trailing = 28.3205
P/E Forward = 22.4719
P/S = 2.6531
P/B = 4.3605
P/EG = 2.5272
Revenue TTM = 19.7b CHF
EBIT TTM = 2.76b CHF
EBITDA TTM = 3.30b CHF
Long Term Debt = 4.21b CHF (from longTermDebt, last quarter)
Short Term Debt = 1.51b CHF (from shortTermDebt, last quarter)
Debt = 6.51b CHF (from shortLongTermDebtTotal, last quarter) + Leases 455.4m
Net Debt = 5.88b CHF (calculated: Debt 6.51b - CCE 625.3m)
Enterprise Value = 35.4b CHF (29.5b + Debt 6.51b - CCE 625.3m)
Interest Coverage Ratio = 17.49 (Ebit TTM 2.76b / Interest Expense TTM 157.9m)
EV/FCF = 28.41x (Enterprise Value 35.4b / FCF TTM 1.25b)
FCF Yield = 3.52% (FCF TTM 1.25b / Enterprise Value 35.4b)
FCF Margin = 6.32% (FCF TTM 1.25b / Revenue TTM 19.7b)
Net Margin = 9.71% (Net Income TTM 1.91b / Revenue TTM 19.7b)
Gross Margin = 48.35% ((Revenue TTM 19.7b - Cost of Revenue TTM 10.2b) / Revenue TTM)
Gross Margin QoQ = 31.87% (prev 54.74%)
Tobins Q-Ratio = 2.21 (Enterprise Value 35.4b / Total Assets 16.0b)
Interest Expense / Debt = 2.43% (Interest Expense 157.9m / Debt 6.51b)
Taxrate = 24.90% (183.1m / 735.2m)
NOPAT = 2.07b (EBIT 2.76b * (1 - 24.90%))
Current Ratio = 1.30 (Total Current Assets 4.95b / Total Current Liabilities 3.81b)
Debt / Equity = 0.96 (Debt 6.51b / totalStockholderEquity, last quarter 6.81b)
Debt / EBITDA = 1.78 (Net Debt 5.88b / EBITDA 3.30b)
Debt / FCF = 4.73 (Net Debt 5.88b / FCF TTM 1.25b)
Total Stockholder Equity = 6.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.17% (Net Income 1.91b / Total Assets 16.0b)
RoE = 28.68% (Net Income TTM 1.91b / Total Stockholder Equity 6.67b)
RoCE = 25.38% (EBIT 2.76b / Capital Employed (Equity 6.67b + L.T.Debt 4.21b))
RoIC = 15.84% (NOPAT 2.07b / Invested Capital 13.1b)
WACC = 7.20% (E(29.5b)/V(36.0b) * Re(8.39%) + D(6.51b)/V(36.0b) * Rd(2.43%) * (1-Tc(0.25)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 6.27 | Cagr: 0.12%
[DCF] Terminal Value 73.96% ; FCFF base≈1.30b ; Y1≈1.20b ; Y5≈1.06b
[DCF] Fair Price = 68.38 (EV 16.9b - Net Debt 5.88b = Equity 11.0b / Shares 160.4m; r=8.35% [WACC [floored]]; 5y FCF grow -10.02% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 79.39 | Revenue CAGR: 10.29% | SUE: 1.21 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=7.43 | Chg30d=+0.28% | Revisions=+46% | GrowthEPS=+11.8% | GrowthRev=+2.0%
EPS next Year (2027-12-31): EPS=8.35 | Chg30d=-0.23% | Revisions=+72% | GrowthEPS=+13.1% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: +68% (up=22, down=3)